Metabolite-enabled eradication of bacterial persisters by aminoglycosides
about
Persisters-as elusive as everAntimicrobial Drugs in Fighting against Antimicrobial ResistanceIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyLyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?Next-generation antimicrobials: from chemical biology to first-in-class drugsAlternatives to antibiotics in animal agriculture: an ecoimmunological viewEscherichia coli physiology and metabolism dictates adaptation to diverse host microenvironmentsNon-genetic diversity shapes infectious capacity and host resistanceMicrobial biofilm formation: a need to actCombination therapies for combating antimicrobial resistanceMicroscale insights into pneumococcal antibiotic mutant selection windowsSelective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms.Mapping the environmental fitness landscape of a synthetic gene circuitBiomaterials and Nanotherapeutics for Enhancing Skin Wound HealingLessons learned and unlearned in periodontal microbiologyThe pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulationsIdentification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicityIdentification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening StrategySynergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumanniiGlucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus PersistersChemogenomics and orthology-based design of antibiotic combination therapiesEndless Resistance. Endless Antibiotics?Temperature-Dependent Gentamicin Resistance of Francisella tularensis is Mediated by Uptake Modulation.Metabolic Perspectives on PersistenceBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Rapid clinical bacteriology and its future impactFructose-enhanced reduction of bacterial growth on nanorough surfaces.Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaDensity-dependent adaptive resistance allows swimming bacteria to colonize an antibiotic gradient.NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.Persistence to anti-cancer treatments in the stationary to proliferating transition.Network-Based Analysis of eQTL Data to Prioritize Driver Mutations.A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance.Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.Antibiotics induce redox-related physiological alterations as part of their lethality.The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin.Phenazine redox cycling enhances anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-motive force.Multidrug evolutionary strategies to reverse antibiotic resistance.Steady-state hydrogen peroxide induces glycolysis in Staphylococcus aureus and Pseudomonas aeruginosa.
P2860
Q26748708-5C1952B1-624E-44F3-BD77-0CAA57A17206Q26752527-AADB4B00-2159-4903-99A6-34825B8A39ECQ26775404-C97FBC04-B1FA-4A01-B0B1-91FFDE8EA340Q26795774-21630835-04A2-4064-BB57-572AED681F0FQ26799749-351AEA42-F430-4BBF-A39D-92B5DA764939Q26822258-9BD1EB17-D8C4-4574-82B7-455845C0246EQ26859181-E332A466-51BD-4803-961C-4B988F049D71Q26864351-1EFBC063-A786-4DDE-BA48-3DD11E4D8D01Q27007396-9BFF8E3C-7B3D-4E7D-A70E-B17C0A00FFBDQ27015710-2999DEC4-8A91-48BD-AD53-CD7421EBC940Q27319262-A76BD3F8-EA08-442A-9848-7489D7A48F91Q27331155-DA09BC58-B446-4310-8EBA-E9CBF2253C40Q27331437-A18EC35C-842E-47FB-82B9-5D6619664F1BQ28077978-3192BBE9-6AC7-4935-8D7C-9C57C1A418FEQ28395398-D61E9984-E984-4941-8FC5-60C716E76C73Q28485988-83D1A9F9-8E70-44FD-8EE9-A8A2AEBD6120Q28542505-4654EC37-56F5-428A-9EF6-5A24467A0434Q28547787-3EA95B5A-2D80-4757-A71E-E2F910AF2F86Q28547854-787BB4FC-A6BD-4A5E-BA1C-86EC97072F32Q28550612-F85150A0-2A64-491C-BA74-C76838E3E2A6Q28817589-58D1BC13-CCC7-480E-B1EC-1AC32CDE8793Q28822179-F3708C0C-6C1F-483E-96CD-BB7280EA4B36Q30391524-8B342EDD-818E-4A45-B97C-39820B8917E9Q30398195-76DAC1FC-0B96-45DB-AB93-32D720B9826FQ30403958-A4B2D00E-7318-49E8-A41F-4E1EB90D9604Q30424697-1D0E5D76-583D-4625-824B-9D2DEA950997Q30459288-38FE77B9-CA3D-44DA-80D8-F1628260335FQ30470545-5C7D27F5-6438-426F-931B-0796EC327304Q30581467-10F4E1C6-3316-45E8-825B-D602C74885CCQ30689718-F05D588A-DE67-4C2D-AD4D-1F83BF464CCBQ30795809-6CA41538-402E-4E20-A25B-626C8D977C8FQ30834504-7D04FA93-06D5-4448-AD0B-EA1064FCDD89Q31039375-79EAD697-2681-4746-A580-3037DB8578C6Q33604647-9E98CBD2-3400-47F6-81EB-7179532ACE2EQ33622796-1120C1FE-2B38-4C6E-9FF7-C988AF4ED95AQ33665248-4ED31DF7-6517-460B-9180-1F3102AFA124Q33711476-87ACB305-AA83-472C-86CD-EF793027CCD1Q33716449-17FB7BBC-02AE-470A-B269-13C7FFE23DC5Q33871101-7FE7B8F6-B7E3-4097-A3C4-64C440764FF6Q33899601-FCC87881-3DB6-4E26-9B5D-63337D27CA0D
P2860
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@ast
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@en
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@nl
type
label
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@ast
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@en
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@nl
prefLabel
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@ast
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@en
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@nl
P2093
P2860
P3181
P356
P1433
P1476
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
@en
P2093
James J Collins
Kyle R Allison
Mark P Brynildsen
P2860
P2888
P304
P3181
P356
10.1038/NATURE10069
P407
P577
2011-05-12T00:00:00Z
P5875
P6179
1021849910